secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001104659-26-049485
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brazilian MAPA bans Phibro's virginiamycin and bacitracin growth promoters; 180-day transition
--------------------------------------------------------------------------------

- MAPA Ordinance 1617 prohibits import, manufacture, marketing and use of antimicrobial feed additives including virginiamycin and bacitracin for growth promotion.
- Transition period of 180 days from April 27, 2026; products can still be sold under current labels during that time.
- Phibro expects new therapeutic registrations for virginiamycin in cattle and broilers during transition; bacitracin already has therapeutic claims.
- Company expects limited impact on fiscal year 2026 results; also launching PhibroVet digital prescription platform.
- Additional details to be provided on May 7, 2026 earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000110465926049485/0001104659-26-049485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000110465926049485/tm2612861d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-049485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer